Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will speak in a fireside chat at the 2024 Leerink Partners Healthcare Crossroads Conference. Quanterix’s presentation is scheduled for Wednesday, May 29, 2024, at 11:40 a.m. ET. The fireside chat will be made available to attendees and to the public via webcast.
Webcast Information
The live webcast of Quanterix’s presentation can be accessed here, and from the Investor section of the company' website at www.Quanterix.com. Replays of the presentation will be available for a limited time following the conference.
To learn more about Quanterix, visit www.quanterix.com/about. To learn more about Quanterix’s Simoa technology, visit: www.quanterix.com/simoa-technology/.
About Quanterix
From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and
flexibility. The Company’s Simoa technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than
the Level of Quantification (LoQ). Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease
understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering
research published in more than 2,900 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https://www.quanterix.com or follow us on Twitter and LinkedIn.
Lesen Sie auch
View source version on businesswire.com: https://www.businesswire.com/news/home/20240522008584/en/
The Quanterix Corporation Stock at the time of publication of the news with a raise of +1,55 % to 17,04USD on Nasdaq stock exchange (22. Mai 2024, 21:44 Uhr).